Andy Staples is the Head of Deal Finance at AstraZeneca, having responsibility for all of the financial analysis, structuring and support for mergers and acquisitions, divestments, in- and out-licensing and strategic equity investments. During a long career at AstraZeneca, he has been involved with all stages of the pharmaceutical value chain from early stage development, through product approval and launch, to patent expiry and post LOE rationalization. Andy has also spent a lot of time working with AstraZeneca Biotech partners structuring and completing multiple deals including the acquisition of Novexel and its portfolio of novel antibiotics. He is a qualified Chartered Accountant and previously worked for PriceWaterhouseCoopers before joining AstraZeneca.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
AstraZeneca | Head of Deal Finance | Jan 1, 1997 | — | Detail |